Skip to Main content Skip to Navigation
Journal articles

Novel reversible monoamine oxidase A inhibitors: highly potent and selective 3-(1H-pyrrol-3-yl)-2-oxazolidinones.

Abstract : Monoamine oxidases (MAOs) are involved in various psychiatric and neurodegenerative disorders; hence, MAO inhibitors are useful agents in the therapy of Parkinson's disease, Alzheimer's dementia, and depression syndrome. Herein we report a novel series of 3-(1H-pyrrol-3-yl)-2-oxazolidinones 3-7 as reversible, highly potent and selective anti-MAO-A agents. In particular, 4b, 5b, and 4c showed a K(i-MAO-A) of 0.6, 0.8, and 1 nM, respectively, 4c being 200000-fold selective for MAO-A with respect to MAO-B.
Document type :
Journal articles
Complete list of metadatas

Cited literature [17 references]  Display  Hide  Download

https://hal-riip.archives-ouvertes.fr/pasteur-00980200
Contributor : Istituto Pasteur Fondazione Cenci Bolognetti <>
Submitted on : Thursday, April 17, 2014 - 3:34:08 PM
Last modification on : Wednesday, October 28, 2020 - 3:20:08 PM
Long-term archiving on: : Monday, April 10, 2017 - 3:05:05 PM

File

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document

Identifiers

Collections

Citation

Sergio Valente, Stefano Tomassi, Giampiero Tempera, Stefania Saccoccio, Enzo Agostinelli, et al.. Novel reversible monoamine oxidase A inhibitors: highly potent and selective 3-(1H-pyrrol-3-yl)-2-oxazolidinones.. Journal of Medicinal Chemistry, American Chemical Society, 2011, 54 (23), pp.8228-32. ⟨10.1021/jm201011x⟩. ⟨pasteur-00980200⟩

Share

Metrics

Record views

122